Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

cMYC Breakapart Test By FISH

The maximum days for obtaining the report for the cMYC Breakapart Test By FISH is 7 days.

What are the prerequisites for the test cMYC Breakapart Test By FISH

  • Specimen: Formalin-fixed, paraffin-embedded tissue block or slides
  • Requisition form with patient information and ordering physician details
  • Completed test request form indicating the need for cMYC Breakapart test by FISH
  • Patient consent form, if required by institutional policy
  • Properly labeled specimen container
  • Transport media for sending the specimen to the laboratory
  • Appropriate shipping and handling instructions for the specimen

What are the measure values for the test cMYC Breakapart Test By FISH

  • Normal/negative result: Two fusion signals (yellow) are observed, indicating that the cMYC gene is intact and not rearranged.
  • Abnormal/positive result: One fusion signal (yellow) and one split signal (green and red) are observed, indicating a rearrangement of the cMYC gene.
  • Indeterminate result: Inconclusive results due to technical issues or poor sample quality.

What does this test cMYC Breakapart Test By FISH identify?

The cMYC Breakapart Test by FISH is a diagnostic test that identifies rearrangements involving the cMYC gene. This test uses fluorescence in situ hybridization (FISH) to detect breaks within the cMYC gene, which can be indicative of certain types of cancer, such as Burkitt lymphoma or other lymphoid malignancies.

Why is this test cMYC Breakapart Test By FISH taken?

The cMYC Breakapart Test By FISH is taken to detect rearrangements in the cMYC gene, which is located on chromosome 8. Rearrangements in the cMYC gene are associated with various types of cancer, particularly lymphomas and leukemias. This test is used to confirm a diagnosis of these cancers, as well as to guide treatment decisions and predict prognosis.

No FAQs available.

Customer Google Rating